Evidence for erythropoietin as a molecular targeting agent

被引：18

作者：

Leyland-Jones, B ^{[1
]}

机构：

[1] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34067

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：145 / 154

页数：10

共 108 条

[21] Molecular mechanisms of erythropoietin signaling [J].

Cheung, JY ;

Miller, BA .

NEPHRON, 2001, 87 (03) :215-222

[22]

Chin H, 1998, BLOOD, V91, P3734

[23] COORDINATE EXPRESSION AND DEVELOPMENTAL ROLE OF ID2 PROTEIN AND TAL1/E2A HETERODIMER IN ERYTHROID PROGENITOR DIFFERENTIATION [J].

CONDORELLI, G ;

VITELLI, L ;

VALTIERI, M ;

MARTA, I ;

MONTESORO, E ;

LULLI, V ;

BAER, R ;

PESCHLE, C .

BLOOD, 1995, 86 (01) :164-175

[24]

CROSSLEY M, 1994, J BIOL CHEM, V269, P15440

[25] The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase [J].

Damen, JE ;

Liu, L ;

Rosten, P ;

Humphries, RK ;

Jefferson, AB ;

Majerus, PW ;

Krystal, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1689-1693

[26]

DAMEN JE, 1993, BLOOD, V81, P3204

[27]

DAMEN JE, 1993, BLOOD, V82, P2296

[28] STATs and gene regulation [J].

Darnell, JE .

SCIENCE, 1997, 277 (5332) :1630-1635

[29] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[30] Exploring the metabolic and genetic control of gene expression on a genomic scale [J].

DeRisi, JL ;

Iyer, VR ;

Brown, PO .

SCIENCE, 1997, 278 (5338) :680-686

← 1 2 3 4 5 6 7 8 9 10 →